Anodyne Nanotech, Inc. is a preclinical-stage biotech company developing differentiated, transdermal forms of high-value drugs. The company’s macroporous microneedle technology provides the first practical and cost-effective platform, Hero Patch, to deliver clinically meaningful doses of macromolecules such as monoclonal antibodies or small molecules (such as ibuprofen) for fast and sustained delivery. We pride ourselves on providing a painless experience for all of those involved in the production, delivery, and consumption of medicines.
Location: United States, Massachusetts, Boston
Employees: 1-10
Founded date: 2019
Investors 3
| Date | Name | Website |
| - | Bantam Gro... | bantamgrou... |
| - | Velocity P... | velocitypa... |
| - | Big Pi | bigpi.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 24.06.2026 | Series A | $12.6M | - |
Mentions in press and media 4
| Date | Title | Description |
| 24.06.2026 | Anodyne Nanotech Raises $12.6M in Series A Funding | Anodyne Nanotech Inc., a Boston, MA-based clinical-stage biotechnology company which specializes in chronic care through transdermal delivery, raised $12.6M in Series a funding. The round was led by Velocity Partners VC and Evercurious VC, ... |
| 04.01.2022 | Industrial Nanotech, Inc. Receives First $865,480 Purchase Order from Nanotech Coatings Ltd | Industrial Nanotech, Inc. announced that it has received the first Purchase Order from Nanotech Coatings Ltd. in the amount of $865,480. This represents the beginning of the company's sales to EU countries, all of which are working to meet ... |
| 03.05.2021 | Anodyne Nanotech Closes $4.2M Seed Financing | Anodyne Nanotech, Inc., a Boston-based biotechnology company developing differentiated, transdermal forms of high-value drugs, closed a $4.2m seed funding. Backers included Velocity Partners, Relativity Healthcare Fund and Big Pi Ventures. ... |
| - | Anodyne Nanotech | “Anodyne Nanotech is a clinical-stage biotech company, developing transdermal premium products for the treatment of chronic diseases. ” |